Loading organizations...
Loading organizations...
Early-stage pharmaceutical company developing RNA activation therapies.
Ractigen Therapeutics has raised $30.0M across 1 funding round.
Ractigen Therapeutics has raised $30.0M in total across 1 funding round.
Ractigen Therapeutics has raised $30.0M in total across 1 funding round.
Ractigen Therapeutics's investors include Guotou Chuangye, CSSD Capital, Eisai, LC Ventures, Xianghe Capital.
Ractigen Therapeutics has raised $30.0M across 1 funding round. Most recently, it raised $30.0M Series A in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 28, 2022 | $30.0M Series A | Guotou Chuangye | CSSD Capital, Eisai, LC Ventures, Xianghe Capital |